Target intelligence / Profile preview

UV excision repair protein RAD23 homolog A (RAD23A)

Target
RAD23A
Molecular classification
DNA repair protein, Ubiquitin-like domain-containing protein, Polyubiquitin chain receptor
01

Overview

UV excision repair protein RAD23 homolog A (RAD23A) is a multifunctional DNA repair factor implicated in the nucleotide excision repair (NER) pathway, responsible for recognizing and repairing bulky lesions in DNA such as those induced by ultraviolet light. RAD23A contains a modular domain structure with an N-terminal ubiquitin-like (UbL) domain, ubiquitin-associated (UbA) domains, and an XPC-binding segment, allowing it to bind single-stranded DNA, interact with polyubiquitin chains, and stabilize the XPC repair complex. Through association with the 26S proteasome and diverse polyubiquitinated substrates, RAD23A participates in maintaining genome stability and regulating protein homeostasis via the ubiquitin-proteasome system. RAD23A is expressed in numerous human tissues and is evolutionarily conserved across species, including yeast and insects. Defects or dysregulation in its pathway are implicated in DNA repair disorders such as xeroderma pigmentosum, and dysregulated repair may contribute to cancer and other diseases involving genomic instability.

Other names
HR23AhHR23AHHR23AMGC111083RAD23yeast homolog ARAD23 homolog Anucleotide excision repair protein RAD23A
02

Mechanism of action

Not applicable (as no drugs directly target this protein; however, RAD23A assists in DNA repair processes and protein degradation via the ubiquitin-proteasome system).

03

Biological functions

Nucleotide excision repair of damaged DNA (NER)DNA damage recognition and tolerance (particularly in response to UV)Delivery of polyubiquitinated proteins to the proteasomeModulation of proteasomal degradation
04

Disease associations

Xeroderma pigmentosum, variant and Group C (associated due to its role in the NER pathway)Other genome instability syndromesCancer (by implication, via its role in DNA repair; literature may reference DNA damage tolerance and tumorigenesis)
05

Safety considerations

Not applicable
06

Interacting drugs

None identified
07

Biomarkers

None currently established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on UV excision repair protein RAD23 homolog A (RAD23A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UV excision repair protein RAD23 homolog A (RAD23A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call